Neurovascular Embolization Devices Market

Global Market Study on Neurovascular Embolization Devices: Minimally Invasive Surgery to Treat Brain Aneurysms by Embolization Coils Aids Steady Revenue Generation

Neurovascular Embolization Devices Market Segmented By Epicardial LAA closure devices and Endocardial LAA closure devices in Diagnostic Laboratories, Hospitals, Academic Research Institutes

- Table of Content -

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. PMR Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Market – Definition by Product Type

3. Global Economic Outlook

    3.1. Healthcare Expenditures, by Region, 2016 - 2021

4. Neurovascular Embolization Devices Market Opportunity Analysis

    4.1. Macro-Economic Factors

    4.2. Opportunity Analysis

5. Market Background

    5.1. Market Dynamics

        5.1.1. Drivers

        5.1.2. Restraints

        5.1.3. Trends

        5.1.4. Opportunity

6. Key Inclusions

    6.1. Reimbursement Scenario

7. North America Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

        7.2.1. U.S.

        7.2.2. Canada

    7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        7.4.1. Embolization Coils

        7.4.2. Liquid Embolic Systems

        7.4.3. Flow Diversion Stents

        7.4.4. Aneurysm Clips

    7.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        7.6.1. Hospitals

        7.6.2. Outpatient Centers

    7.7. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    7.8. Market Attractiveness Analysis

        7.8.1. By Country

        7.8.2. By Product Type

        7.8.3. By End Users

    7.9. Drivers and Restraints: Impact Analysis

8. Latin America Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

        8.2.1. Argentina

        8.2.2. Brazil

        8.2.3. Rest of LA

    8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

    8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        8.4.1. Embolization Coils

        8.4.2. Liquid Embolic Systems

        8.4.3. Flow Diversion Stents

        8.4.4. Aneurysm Clips

    8.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        8.6.1. Hospitals

        8.6.2. Outpatient Centers

    8.7. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    8.8. Market Attractiveness Analysis

        8.8.1. By Country

        8.8.2. By Product Type

        8.8.3. By End Users

    8.9. Drivers and Restraints: Impact Analysis

9. Europe Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

        9.2.1. Germany

        9.2.2. United Kingdom

        9.2.3. France

        9.2.4. Italy

        9.2.5. Spain

        9.2.6. Russia

        9.2.7. Rest of Europe

    9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        9.4.1. Embolization Coils

        9.4.2. Liquid Embolic Systems

        9.4.3. Flow Diversion Stents

        9.4.4. Aneurysm Clips

    9.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        9.6.1. Hospitals

        9.6.2. Outpatient Centers

    9.7. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    9.8. Market Attractiveness Analysis

        9.8.1. By Country

        9.8.2. By Product Type

        9.8.3. By End Users

    9.9. Drivers and Restraints: Impact Analysis

10. APAC Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

        10.2.1. Australia

        10.2.2. China

        10.2.3. India

        10.2.4. Japan

        10.2.5. Rest of APAC

    10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        10.4.1. Embolization Coils

        10.4.2. Liquid Embolic Systems

        10.4.3. Flow Diversion Stents

        10.4.4. Aneurysm Clips

    10.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        10.6.1. Hospitals

        10.6.2. Outpatient Centers

    10.7. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    10.8. Market Attractiveness Analysis

        10.8.1. By Country

        10.8.2. By Product Type

        10.8.3. By End Users

    10.9. Drivers and Restraints: Impact Analysis

11. Middle East and Africa Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

        11.2.1. Saudi Arabia

        11.2.2. South Africa

        11.2.3. Rest of MEA

    11.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        11.4.1. Embolization Coils

        11.4.2. Liquid Embolic Systems

        11.4.3. Flow Diversion Stents

        11.4.4. Aneurysm Clips

    11.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        11.6.1. Hospitals

        11.6.2. Outpatient Centers

    11.7. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    11.8. Market Attractiveness Analysis

        11.8.1. By Country

        11.8.2. By Product Type

        11.8.3. By End Users

    11.9. Drivers and Restraints: Impact Analysis

12. Forecast Factors: Relevance and Impact

13. Competition Landscape

    13.1. Competition Dashboard

    13.2. Company Deep Dive

        13.2.1. Medtronic plc

            13.2.1.1. Overview

            13.2.1.2. Product and End Users Portfolio

            13.2.1.3. Production Footprint

            13.2.1.4. Sales Footprint

            13.2.1.5. Channel Footprint

            13.2.1.6. Strategy

                13.2.1.6.1. Marketing Strategy

                13.2.1.6.2. Product Strategy

                13.2.1.6.3. Channel Strategy

        13.2.2. Stryker Corporation

            13.2.2.1. Overview

            13.2.2.2. Product and End Users Portfolio

            13.2.2.3. Production Footprint

            13.2.2.4. Sales Footprint

            13.2.2.5. Channel Footprint

            13.2.2.6. Strategy

                13.2.2.6.1. Marketing Strategy

                13.2.2.6.2. Product Strategy

                13.2.2.6.3. Channel Strategy

        13.2.3. Terumo Corporation

            13.2.3.1. Overview

            13.2.3.2. Product and End Users Portfolio

            13.2.3.3. Production Footprint

            13.2.3.4. Sales Footprint

            13.2.3.5. Channel Footprint

            13.2.3.6. Strategy

                13.2.3.6.1. Marketing Strategy

                13.2.3.6.2. Product Strategy

                13.2.3.6.3. Channel Strategy

        13.2.4. Johnson & Johnson Services, Inc.

            13.2.4.1. Overview

            13.2.4.2. Product and End Users Portfolio

            13.2.4.3. Production Footprint

            13.2.4.4. Sales Footprint

            13.2.4.5. Channel Footprint

            13.2.4.6. Strategy

                13.2.4.6.1. Marketing Strategy

                13.2.4.6.2. Product Strategy

                13.2.4.6.3. Channel Strategy

        13.2.5. Penumbra Inc.

            13.2.5.1. Overview

            13.2.5.2. Product and End Users Portfolio

            13.2.5.3. Production Footprint

            13.2.5.4. Sales Footprint

            13.2.5.5. Channel Footprint

            13.2.5.6. Strategy

                13.2.5.6.1. Marketing Strategy

                13.2.5.6.2. Product Strategy

                13.2.5.6.3. Channel Strategy

        13.2.6. Balt Extrusion S.A

            13.2.6.1. Overview

            13.2.6.2. Product and End Users Portfolio

            13.2.6.3. Production Footprint

            13.2.6.4. Sales Footprint

            13.2.6.5. Channel Footprint

            13.2.6.6. Strategy

                13.2.6.6.1. Marketing Strategy

                13.2.6.6.2. Product Strategy

                13.2.6.6.3. Channel Strategy

        13.2.7. B. Braun Melsungen AG.

            13.2.7.1. Overview

            13.2.7.2. Product and End Users Portfolio

            13.2.7.3. Production Footprint

            13.2.7.4. Sales Footprint

            13.2.7.5. Channel Footprint

            13.2.7.6. Strategy

                13.2.7.6.1. Marketing Strategy

                13.2.7.6.2. Product Strategy

                13.2.7.6.3. Channel Strategy

        13.2.8. Integra LifeSciences Corporation

            13.2.8.1. Overview

            13.2.8.2. Product and End Users Portfolio

            13.2.8.3. Production Footprint

            13.2.8.4. Sales Footprint

            13.2.8.5. Channel Footprint

            13.2.8.6. Strategy

                13.2.8.6.1. Marketing Strategy

                13.2.8.6.2. Product Strategy

                13.2.8.6.3. Channel Strategy

        13.2.9. Resonetics Llc

            13.2.9.1. Overview

            13.2.9.2. Product and End Users Portfolio

            13.2.9.3. Production Footprint

            13.2.9.4. Sales Footprint

            13.2.9.5. Channel Footprint

            13.2.9.6. Strategy

                13.2.9.6.1. Marketing Strategy

                13.2.9.6.2. Product Strategy

                13.2.9.6.3. Channel Strategy

        13.2.10. Acandis GmbH

            13.2.10.1. Overview

            13.2.10.2. Product and End Users Portfolio

            13.2.10.3. Production Footprint

            13.2.10.4. Sales Footprint

            13.2.10.5. Channel Footprint

            13.2.10.6. Strategy

                13.2.10.6.1. Marketing Strategy

                13.2.10.6.2. Product Strategy

                13.2.10.6.3. Channel Strategy

14. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028 By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Region

        14.2.1. North America

        14.2.2. Latin America

        14.2.3. Europe

        14.2.4. APAC

        14.2.5. Middle East and Africa

    14.3. Market Size (US$ Mn) Forecast By Region

    14.4. Market Attractiveness Analysis By Region

15. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028, By Product Type

    15.1. Introduction/Key Finding

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

        15.2.1. Embolization Coils

        15.2.2. Liquid Embolic Systems

        15.2.3. Flow Diversion Stents

        15.2.4. Aneurysm Clips

    15.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

    15.4. Market Attractiveness Analysis By Product Type

16. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028, By End Users

    16.1. Introduction/Key Finding

    16.2. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2013-2017

        16.2.1. Hospitals

        16.2.2. Outpatient Centers

    16.3. Market Size (US$ Mn) Forecast By End Users, 2018-2028

    16.4. Market Attractiveness Analysis By End Users

17. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028

    17.1. Market Value Share Analysis By All Segment

    17.2. Y-o-Y Growth Analysis By All Segment

    17.3. Absolute $ Opportunity

18. Assumptions and Acronyms Used

19. Research Methodology

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: CPT code for Neurovascular Treatment of Aneurysms

Table 04: CPT code for Neurovascular Treatment of Aneurysms

Table 05: CPT code for Neurovascular Treatment of Aneurysms

Table 06: North America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 07: North America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 08: North America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Table 09: Latin America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 10: Latin America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 11: Latin America Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Table 12: Europe Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 13: Europe Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 14: Europe Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Table 15: APAC Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 16: APAC Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 17: APAC Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Table 18: MEA Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

Table 19: MEA Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 20: MEA Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Table 21: Global Neurovascular Embolization Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2027, By Region

Table 22: Global Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Table 23: Global Neurovascular Embolization Devices Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By End Users

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 01: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 02: North America Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 03: North America Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 04: North America Neurovascular Embolization Devices Market Share Analysis (%), By Country, 2018 & 2028

Figure 05: North America Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 06: North America Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 07: U.S. Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 08: U.S. Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 09: Canada Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 10: Canada Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 11: North America Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type, 2018-2028

Figure 12: North America Neurovascular Embolization Devices Market Attractiveness Analysis by End Users, 2018-2028

Figure 13: North America Neurovascular Embolization Devices Market Attractiveness Analysis by Country, 2018-2028

Figure 14: Latin America Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 15: Latin America Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 16: Latin America Neurovascular Embolization Devices Market Share Analysis (%), By Country, 2018 & 2028

Figure 17: Latin America Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 18: Latin America Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 19: Brazil Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 20: Brazil Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 21: Argentina Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 22: Argentina Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 23: Rest of Latin America Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 24: Rest of Latin America Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 25: Latin America Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type, 2018-2028

Figure 26: Latin America Neurovascular Embolization Devices Market Attractiveness Analysis by End Users, 2018-2028

Figure 27: Latin America Neurovascular Embolization Devices Market Attractiveness Analysis by Country, 2018-2028

Figure 28: Europe Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 29: Europe Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 30: Europe Neurovascular Embolization Devices Market Share Analysis (%), By Country, 2018 & 2028

Figure 31: Europe Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 32: Europe Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 33: Germany Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 34: Germany Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 35: U.K. Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 36: U.K. Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 37: France Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 38: France Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 39: Italy Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 40: Italy Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 41: Spain Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 42: Spain Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 43: Russia Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 44: Russia Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 45: Rest of Europe Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 46: Rest of Europe Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 47: Europe Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type, 2018-2028

Figure 48: Europe Neurovascular Embolization Devices Market Attractiveness Analysis by End Users, 2018-2028

Figure 49: Europe Neurovascular Embolization Devices Market Attractiveness Analysis by Country, 2018-2028

Figure 50: APAC Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 51: APAC Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 52: APAC Neurovascular Embolization Devices Market Share Analysis (%), By Country, 2018 & 2028

Figure 53: APAC Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 54: APAC Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 55: Australia Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 56: Australia Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 57: China Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 58: China Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 59: India Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 60: India Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 61: Japan Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 62: Japan Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 63: Rest of APAC Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 64: Rest of APAC Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 65: APAC Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type, 2018-2028

Figure 66: APAC Neurovascular Embolization Devices Market Attractiveness Analysis by End Users, 2018-2028

Figure 67: APAC Neurovascular Embolization Devices Market Attractiveness Analysis by Country, 2018-2028

Figure 68: MEA Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 69: MEA Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 70: MEA Neurovascular Embolization Devices Market Share Analysis (%), By Country, 2018 & 2028

Figure 71: MEA Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 72: MEA Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 73: Saudi Arabia Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 74: Saudi Arabia Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 75: South Africa Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 76: South Africa Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 77: Rest of MEA Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 78: Rest of MEA Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 79: MEA Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type, 2018-2028

Figure 80: MEA Neurovascular Embolization Devices Market Attractiveness Analysis by End Users, 2018-2028

Figure 81: MEA Neurovascular Embolization Devices Market Attractiveness Analysis by Country, 2018-2028

Figure 82: Global Neurovascular Embolization Devices Market Share Analysis (%), By Region, 2018 & 2028

Figure 83: Global Neurovascular Embolization Devices Market Y-o-Y Analysis (%), By Region, 2018-2028

Figure 84: Global Neurovascular Embolization Devices Market Attractiveness Analysis by Region, 2018-2028

Figure 85: Global Neurovascular Embolization Devices Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 86: Global Neurovascular Embolization Devices Market Y-o-Y Analysis (%), By Product Type, 2018-2028

Figure 87: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn) by embolization coils, 2013-2017

Figure 88: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by embolization coils, 2018-2028

Figure 89: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by liquid embolic systems, 2013-2017

Figure 90: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn,) by liquid embolic systems, 2018-2028

Figure 91: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by flow diversion stents, 2013-2017

Figure 92: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn),by flow diversion stents, 2018-2028

Figure 93: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by aneurysms clips, 2013-2017

Figure 94: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by aneurysms clips, 2018-2028

Figure 95: Global Neurovascular Embolization Devices Market Attractiveness Analysis by Product Type , 2018-2028

Figure 96: Global Neurovascular Embolization Devices Market Share Analysis (%), By End Users, 2018 & 2028

Figure 97: Global Neurovascular Embolization Devices Market Y-o-Y Analysis (%), By End Users, 2018-2028

Figure 98: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn, by Hospitals, 2013-2017

Figure 99: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by Hospitals, 2018-2028

Figure 100: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by Outpatient Centers, 2013-2017

Figure 101: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), by Outpatient Centers, 2018-2028

Figure 102: Global Neurovascular Embolization Devices Market Attractiveness Analysis by End Users , 2018-2028

Figure 103: Global Neurovascular Embolization Devices Market Value Analysis (US$ Mn), 2013-2017

Figure 104: Global Neurovascular Embolization Devices Market Value Forecast (US$ Mn), 2018-2028

Figure 105: Global Neurovascular Embolization Devices Market Absolute $ Opportunity, 2018 – 2028

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate